FDA told Leading Edge Health its Erectin Stimulating Gel and VigRX Delay Wipes are unapproved new drugs based on claims on its website.
What happened
FDA reviewed the company's website, leadingedgehealth.com, in May 2026 rather than conducting an inspection. The agency said labeling on the site, such as "INSTANT ERECTION formula" and a numbing effect "perfect for guys who ejaculate too early," shows the two products are intended to affect the body and are therefore drugs. Because FDA has not approved them, the letter calls them unapproved new drugs that cannot legally be sold across state lines.
What FDA found
Website claims such as "INSTANT ERECTION formula" and "Rock Hard Erections" show the gel is meant to change how the body works, which makes it a drug.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)Website claims for the wipes, including numbing for early ejaculation and anti-fungal use, show they are meant to treat or affect the body, which makes them drugs.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)Both products are "new drugs" because they are not generally recognized as safe and effective for their labeled uses.
FD&C Act section 201(p), 21 U.S.C. 321(p)Neither product has an FDA-approved application, so they cannot be sold across state lines.
FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)
What FDA wants
FDA told the company to send a written response to FDAAdvisory@fda.hhs.gov within 15 business days of receiving the letter, listing the steps taken to fix the violations, how it will prevent them from happening again, and supporting documents, with reference number 729193 in the subject line.
Who should pay attention
- online sellers of male-enhancement or intimate topical products
- brands whose websites make drug-like claims for gels, wipes or supplements
- labelers and contract manufacturers of topical gels and wipes
This is a summary. Read the original letter on fda.gov.